A phase 1 study of enoblituzumab in combination with pembrolizumab in patients with advanced B7-H3-expressing cancers
- Resource Type
- Journal
- Source
JOURNAL OF CLINICAL ONCOLOGY ; MAY 20 2016, 34 15, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15277755